シスタチンC (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "シスタチンC" in Japanese language version.

refsWebsite

Global rank Japanese rank

115nih.gov

4^th place

24^th place

89doi.org

2^nd place

6^th place

13web.archive.org

1^st place

4archive.is

87^th place

39^th place

2ensembl.org

1,626^th place

2,625^th place

2wikipedia.org

low place

2karger.com

4,489^th place

low place

2asnjournals.org

low place

2annals.org

low place

9,895^th place

2archive.today

14^th place

320^th place

2ama-assn.org

3,257^th place

6,629^th place

2ahajournals.org

3,608^th place

7,627^th place

2lu.se

4,012^th place

low place

2harvard.edu

18^th place

107^th place

1diabetesjournals.org

low place

1rbac.org.br

low place

1nice.org.uk

3,258^th place

1,755^th place

1kurtis.it

low place

1qub.ac.uk

8,565^th place

low place

1ulg.ac.be

7,875^th place

low place

1handle.net

102^nd place

78^th place

1amjpathol.org

low place

1aacrjournals.org

8,869^th place

low place

aacrjournals.org

clincancerres.aacrjournals.org

“Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis”. Clinical Cancer Research 6 (2): 505–11. (February 2000). PMID 10690531. Archived 2013年2月23日, at Archive.is

ahajournals.org

circ.ahajournals.org

ama-assn.org

archinte.ama-assn.org

“Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study”. Archives of Internal Medicine 167 (20): 2213–9. (November 2007). doi:10.1001/archinte.167.20.2213. PMC 3189482. PMID 17998494. オリジナルの2008-06-07時点におけるアーカイブ。. Archived 2008年6月7日, at Archive.is
“Cystatin C and aging success”. Archives of Internal Medicine 168 (2): 147–53. (January 2008). doi:10.1001/archinternmed.2007.40. PMC 2871318. PMID 18227360. オリジナルの2008-06-07時点におけるアーカイブ。. Archived 2008年6月7日, at Archive.is

amjpathol.org

ajp.amjpathol.org

“Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases”. The American Journal of Pathology 170 (3): 809–17. (March 2007). doi:10.2353/ajpath.2007.060522. PMC 1864891. PMID 17322367. ^{[リンク切れ]}

annals.org

archive.is

archive.today

“Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study”. Archives of Internal Medicine 167 (20): 2213–9. (November 2007). doi:10.1001/archinte.167.20.2213. PMC 3189482. PMID 17998494. オリジナルの2008-06-07時点におけるアーカイブ。. Archived 2008年6月7日, at Archive.is
“Cystatin C and aging success”. Archives of Internal Medicine 168 (2): 147–53. (January 2008). doi:10.1001/archinternmed.2007.40. PMC 2871318. PMID 18227360. オリジナルの2008-06-07時点におけるアーカイブ。. Archived 2008年6月7日, at Archive.is

asnjournals.org

jasn.asnjournals.org

“Dietary protein and renal function”. Journal of the American Society of Nephrology 3 (11): 1723–37. (May 1993). doi:10.1681/ASN.V3111723. PMID 8329667. アーカイブ 2023年4月7日 - ウェイバックマシン
“Chronic kidney disease and mortality risk: a systematic review”. Journal of the American Society of Nephrology 17 (7): 2034–47. (July 2006). doi:10.1681/ASN.2005101085. PMID 16738019.

diabetesjournals.org

care.diabetesjournals.org

“Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes”. Diabetes Care 31 (5): 971–3. (May 2008). doi:10.2337/dc07-1588. PMID 18319326. Archived 2013年4月14日, at Archive.is

doi.org

“Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review”. American Journal of Nephrology 27 (2): 197–205. (2007). doi:10.1159/000100907. PMID 17361076. アーカイブ 2023年5月21日 - ウェイバックマシン
“Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis”. Clinical Biochemistry 40 (5–6): 383–91. (March 2007). doi:10.1016/j.clinbiochem.2006.10.026. PMID 17316593.
“Dietary protein and renal function”. Journal of the American Society of Nephrology 3 (11): 1723–37. (May 1993). doi:10.1681/ASN.V3111723. PMID 8329667. アーカイブ 2023年4月7日 - ウェイバックマシン
“Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis”. American Journal of Kidney Diseases 40 (2): 221–6. (August 2002). doi:10.1053/ajkd.2002.34487. PMID 12148093.
“Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes”. Diabetes Care 31 (5): 971–3. (May 2008). doi:10.2337/dc07-1588. PMID 18319326. Archived 2013年4月14日, at Archive.is
“Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study”. Journal of the American Society of Nephrology 16 (5): 1404–12. (May 2005). doi:10.1681/ASN.2004100854. PMC 2429917. PMID 15788478.
“Serum cystatin C as a reliable marker of changes in glomerular filtration rate in children with urinary tract malformations”. The Journal of Urology 175 (1): 303–9. (January 2006). doi:10.1016/S0022-5347(05)00015-7. PMID 16406933.
“Cystatin C: a kidney function biomarker”. Adv Clin Chem 68: 57–69. (2015). doi:10.1016/bs.acc.2014.11.007. PMID 25858868.
“Cystatin C as a biomarker for estimating glomerular filtration rate”. Curr Opin Nephrol Hypertens 24 (3): 295–300. (May 2015). doi:10.1097/MNH.0000000000000115. PMID 26066476.
“Cystatin C: a promising biomarker to evaluate renal function”. Revista Brasileira de Analises Clinicas 49 (3). (January 1, 2017). doi:10.21877/2448-3877.201600446 2020年11月18日閲覧。. アーカイブ 2023年4月10日 - ウェイバックマシン
“Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease”. Annals of Internal Medicine 145 (4): 237–46. (August 2006). doi:10.7326/0003-4819-145-4-200608150-00003. PMID 16908914. アーカイブ 2012年9月11日 - ウェイバックマシン
“A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup”. Geroscience 40 (5–6): 419–436. (December 2018). doi:10.1007/s11357-018-0042-y. PMC 6294728. PMID 30151729.
“Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin”. Therapeutic Drug Monitoring 28 (3): 326–31. (June 2006). doi:10.1097/01.ftd.0000211805.89440.3d. PMID 16778715.
“Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment”. International Journal of Clinical Pharmacology and Therapeutics 42 (2): 93–7. (February 2004). doi:10.5414/cpp42093. PMID 15180169.
“Cystatin C can be affected by nonrenal factors: a preliminary study on leukemia”. Clinical Biochemistry 39 (2): 115–8. (February 2006). doi:10.1016/j.clinbiochem.2005.10.009. PMID 16337174.
“Serum levels of cystatin C in patients with malignancy”. Clinical and Experimental Nephrology 12 (2): 132–139. (April 2008). doi:10.1007/s10157-008-0043-8. PMID 18317874.
“Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression”. Clinical Chemistry 44 (12): 2556–7. (December 1998). doi:10.1093/clinchem/44.12.2556. PMID 9836733.
“Impact of thyroid dysfunction on serum cystatin C”. Kidney International 63 (5): 1944–7. (May 2003). doi:10.1046/j.1523-1755.2003.00925.x. PMID 12675875.
“Thyroid function differently affects serum cystatin C and creatinine concentrations”. Journal of Endocrinological Investigation 28 (4): 346–9. (April 2005). doi:10.1007/bf03347201. PMID 15966508. オリジナルの2008-06-08時点におけるアーカイブ。. アーカイブ 2008年6月8日 - ウェイバックマシン
“Serum cystatin C is sensitive to small changes in thyroid function”. Clinica Chimica Acta; International Journal of Clinical Chemistry 338 (1–2): 87–90. (December 2003). doi:10.1016/j.cccn.2003.07.022. PMID 14637271.
“Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients”. Clinical Chemistry 47 (11): 2055–9. (November 2001). doi:10.1093/clinchem/47.11.2055. PMID 11673383.
“Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients”. Clinica Chimica Acta; International Journal of Clinical Chemistry 300 (1–2): 83–95. (October 2000). doi:10.1016/S0009-8981(00)00298-9. PMID 10958865.
“Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations”. Clinical Chemistry 48 (7): 1123–6. (July 2002). doi:10.1093/clinchem/48.7.1123. PMID 12089191.
“Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement”. Kidney International 65 (4): 1416–21. (April 2004). doi:10.1111/j.1523-1755.2004.00517.x. PMID 15086483.
“Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study”. Archives of Internal Medicine 167 (20): 2213–9. (November 2007). doi:10.1001/archinte.167.20.2213. PMC 3189482. PMID 17998494. オリジナルの2008-06-07時点におけるアーカイブ。. Archived 2008年6月7日, at Archive.is
“Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidin-biotin ELISA assay for its measurement”. Journal of Immunoassay 13 (1): 47–60. (1992). doi:10.1080/15321819208019824. PMID 1569212.
“Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration”. Antiviral Therapy 11 (5): 641–5. (2006). doi:10.1177/135965350601100502. PMID 16964834.
“Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy”. Scandinavian Journal of Clinical and Laboratory Investigation 62 (2): 141–7. (2002). doi:10.1080/003655102753611771. PMID 12004930.
“Cystatin-C and beta trace protein as markers of renal function in pregnancy”. BJOG 112 (5): 575–8. (May 2005). doi:10.1111/j.1471-0528.2004.00492.x. PMID 15842279.
“Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans”. Scandinavian Journal of Clinical and Laboratory Investigation 65 (2): 111–24. (2005). doi:10.1080/00365510510013523. PMID 16025834.
“Chronic kidney disease and mortality risk: a systematic review”. Journal of the American Society of Nephrology 17 (7): 2034–47. (July 2006). doi:10.1681/ASN.2005101085. PMID 16738019.
“Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization”. The New England Journal of Medicine 351 (13): 1296–305. (September 2004). doi:10.1056/NEJMoa041031. PMID 15385656.
“Use of multiple biomarkers to improve the prediction of death from cardiovascular causes”. The New England Journal of Medicine 358 (20): 2107–16. (May 2008). doi:10.1056/NEJMoa0707064. PMID 18480203.
“Cystatin C and the risk of death and cardiovascular events among elderly persons”. The New England Journal of Medicine 352 (20): 2049–60. (May 2005). doi:10.1056/NEJMoa043161. PMID 15901858.
“Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study”. Circulation 115 (2): 173–9. (January 2007). doi:10.1161/CIRCULATIONAHA.106.644286. PMC 2771187. PMID 17190862. Archived 2013年2月23日, at Archive.is
“Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study”. American Heart Journal 155 (1): 62–8. (January 2008). doi:10.1016/j.ahj.2007.08.012. PMID 18082491.
“Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate”. Clinical Chemistry 51 (2): 321–7. (February 2005). doi:10.1373/clinchem.2004.041889. PMID 15563478.
“Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome”. Circulation 110 (16): 2342–8. (October 2004). doi:10.1161/01.CIR.0000145166.44942.E0. PMID 15477399. Archived 2013年2月23日, at Archive.is
“Plasma cystatin-C and development of coronary heart disease: The PRIME Study”. Atherosclerosis 185 (2): 375–80. (April 2006). doi:10.1016/j.atherosclerosis.2005.06.017. PMID 16046222. アーカイブ 2019年4月26日 - ウェイバックマシン
“Is serum cystatin-C a reliable marker for metabolic syndrome?”. The American Journal of Medicine 121 (5): 426–32. (May 2008). doi:10.1016/j.amjmed.2008.01.040. PMID 18456039.
“Cystatin C as a risk factor for outcomes in chronic kidney disease”. Annals of Internal Medicine 147 (1): 19–27. (July 2007). doi:10.7326/0003-4819-147-1-200707030-00004. PMID 17606957. アーカイブ 2012年9月11日 - ウェイバックマシン
“Cystatin C and aging success”. Archives of Internal Medicine 168 (2): 147–53. (January 2008). doi:10.1001/archinternmed.2007.40. PMC 2871318. PMID 18227360. オリジナルの2008-06-07時点におけるアーカイブ。. Archived 2008年6月7日, at Archive.is
“Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)”. American Heart Journal 155 (1): 82–6. (January 2008). doi:10.1016/j.ahj.2007.08.023. PMC 2179893. PMID 18082494.
“Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study”. Archives of Internal Medicine 165 (22): 2666–70. (2005). doi:10.1001/archinte.165.22.2666. PMID 16344426.
“Chronic kidney disease in the elderly--how to assess risk”. The New England Journal of Medicine 352 (20): 2122–4. (May 2005). doi:10.1056/NEJMe058035. PMID 15901867.
“Cystatin C, renal function, and cardiovascular risk”. Annals of Internal Medicine 148 (4): 323. (February 2008). doi:10.7326/0003-4819-148-4-200802190-00023. hdl:2268/4787. PMID 18283218. アーカイブ 2023年4月7日 - ウェイバックマシン
“Glomerular protein sieving and implications for renal failure in Fanconi syndrome”. Kidney International 60 (5): 1885–92. (November 2001). doi:10.1046/j.1523-1755.2001.00016.x. PMID 11703607.
“Renal handling of radiolabelled human cystatin C in the rat”. Scandinavian Journal of Clinical and Laboratory Investigation 56 (5): 409–14. (August 1996). doi:10.3109/00365519609088795. PMID 8869663.
“Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'”. Scandinavian Journal of Clinical and Laboratory Investigation 75 (4): 333–40. (July 2015). doi:10.3109/00365513.2015.1025427. PMC 4487590. PMID 25919022.
“Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options”. Clinical Biochemistry Online ahead of print: 12–20. (June 2020). doi:10.1016/j.clinbiochem.2020.06.002. PMID 32544475.
“Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases”. The Journal of Experimental Medicine 169 (5): 1771–8. (May 1989). doi:10.1084/jem.169.5.1771. PMC 2189307. PMID 2541223.
“The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models”. Brain Pathology 16 (1): 60–70. (January 2006). doi:10.1111/j.1750-3639.2006.tb00562.x. PMC 8095742. PMID 16612983.
“Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping”. Nature Structural Biology 8 (4): 316–320. (April 2001). doi:10.1038/86188. PMID 11276250. https://lup.lub.lu.se/record/131360.
“Glomerular protein sieving and implications for renal failure in Fanconi syndrome”. Proteins 61 (3): 570–578–92. (Nov 2005). doi:10.1002/prot.20633. PMID 16170782.
“Structural characterization of covalently stabilized human cystatin C oligomers”. International Journal of Molecular Sciences 21 (5860): 5860. (Aug 2020). doi:10.3390/ijms21165860. PMC 7461555. PMID 32824145.
“Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models”. Nature Genetics 39 (12): 1440–2. (December 2007). doi:10.1038/ng.2007.29. PMID 18026100.
“Cystatin C modulates cerebral beta-amyloidosis”. Nature Genetics 39 (12): 1437–9. (December 2007). doi:10.1038/ng.2007.23. PMID 18026102.
“Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database”. Nature Genetics 39 (1): 17–23. (January 2007). doi:10.1038/ng1934. PMID 17192785.
“Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease”. Dementia and Geriatric Cognitive Disorders 23 (4): 251–7. (2007). doi:10.1159/000100021. PMID 17310123. アーカイブ 2023年4月7日 - ウェイバックマシン
“Cleavage of cystatin C is not associated with multiple sclerosis”. Annals of Neurology 62 (2): 201–4; discussion 205. (August 2007). doi:10.1002/ana.20968. PMID 17006926.
“Cystatin C deficiency in human atherosclerosis and aortic aneurysms”. The Journal of Clinical Investigation 104 (9): 1191–7. (November 1999). doi:10.1172/JCI7709. PMC 409823. PMID 10545518. アーカイブ 2023年4月7日 - ウェイバックマシン
“Cysteine protease activity in the wall of abdominal aortic aneurysms”. Journal of Vascular Surgery 46 (6): 1260–6. (December 2007). doi:10.1016/j.jvs.2007.08.015. PMID 18155003.
“Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases”. The American Journal of Pathology 170 (3): 809–17. (March 2007). doi:10.2353/ajpath.2007.060522. PMC 1864891. PMID 17322367. ^{[リンク切れ]}
“Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms”. The British Journal of Surgery 91 (1): 86–9. (January 2004). doi:10.1002/bjs.4364. PMID 14716800.
“Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms”. The British Journal of Surgery 88 (11): 1472–5. (November 2001). doi:10.1046/j.0007-1323.2001.01911.x. PMID 11683743.
“CST3 genotype associated with exudative age related macular degeneration”. The British Journal of Ophthalmology 86 (2): 214–9. (February 2002). doi:10.1136/bjo.86.2.214. PMC 1771004. PMID 11815350.
“The role of cathepsins in ocular physiology and pathology”. Experimental Eye Research 84 (3): 383–8. (March 2007). doi:10.1016/j.exer.2006.05.017. PMID 16893541.
“Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis”. British Journal of Cancer 90 (10): 1961–8. (May 2004). doi:10.1038/sj.bjc.6601830. PMC 2409457. PMID 15138478.
“Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies”. BJOG 110 (9): 825–30. (September 2003). doi:10.1111/j.1471-0528.2003.02051.x. PMID 14511964.
“Cystatin C and preeclampsia: a case control study”. Renal Failure 30 (1): 89–95. (2008). doi:10.1080/08860220701742229. PMID 18197549.
“Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia”. Acta Obstetricia et Gynecologica Scandinavica 86 (8): 921–6. (2007). doi:10.1080/00016340701318133. PMID 17653875.
“Increased cystatin C expression in the pre-eclamptic placenta”. Molecular Human Reproduction 13 (3): 189–95. (March 2007). doi:10.1093/molehr/gal111. PMID 17227816.
“Adult cystatin C reference intervals determined by nephelometric immunoassay”. Clinical Biochemistry 40 (13–14): 1084–7. (September 2007). doi:10.1016/j.clinbiochem.2007.05.011. PMID 17624320.
“Serum cystatin C may be a better marker of renal impairment than creatinine”. Journal of the American Geriatrics Society 51 (11): 1674; author reply 1674-5. (November 2003). doi:10.1046/j.1532-5415.2003.515244.x. PMID 14687406.
“Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program”. Clinical Chemistry 52 (1): 5–18. (January 2006). doi:10.1373/clinchem.2005.0525144. PMID 16332993.
“Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III)”. American Journal of Kidney Diseases 51 (3): 385–94. (March 2008). doi:10.1053/j.ajkd.2007.11.019. PMID 18295054.
“Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children”. Archives of Disease in Childhood 82 (1): 71–5. (January 2000). doi:10.1136/adc.82.1.71. PMC 1718178. PMID 10630919.
“Cystatin C reference values and aging”. Clinical Biochemistry 39 (6): 658–61. (June 2006). doi:10.1016/j.clinbiochem.2006.03.017. PMID 16730690.
“Cystatin C as a marker of GFR--history, indications, and future research”. Clinical Biochemistry 38 (1): 1–8. (January 2005). doi:10.1016/j.clinbiochem.2004.09.025. PMID 15607309.
“Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD”. American Journal of Kidney Diseases 51 (3): 395–406. (March 2008). doi:10.1053/j.ajkd.2007.11.018. PMC 2390827. PMID 18295055.
“Cystatin C: research priorities targeted to clinical decision making”. American Journal of Kidney Diseases 51 (3): 358–61. (March 2008). doi:10.1053/j.ajkd.2008.01.002. PMID 18295049.
“Overweight, obesity, and elevated serum cystatin C levels in adults in the United States”. The American Journal of Medicine 121 (4): 341–8. (April 2008). doi:10.1016/j.amjmed.2008.01.003. PMC 3049932. PMID 18374694.
“A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study”. BMC Medical Genetics 8 Suppl 1 (Suppl 1): S10. (September 2007). doi:10.1186/1471-2350-8-S1-S10. PMC 1995611. PMID 17903292.
“Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping”. Nature Structural Biology 8 (4): 316–20. (April 2001). doi:10.1038/86188. PMID 11276250. アーカイブ 2021年4月19日 - ウェイバックマシン
“Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis”. Proceedings of the National Academy of Sciences of the United States of America 79 (9): 3024–7. (May 1982). Bibcode: 1982PNAS...79.3024G. doi:10.1073/pnas.79.9.3024. PMC 346341. PMID 6283552.
“Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system”. Scandinavian Journal of Clinical and Laboratory Investigation 39 (7): 619–26. (November 1979). doi:10.3109/00365517909108866. PMID 119302.
“Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate”. Acta Medica Scandinavica 218 (5): 499–503. (1985). doi:10.1111/j.0954-6820.1985.tb08880.x. PMID 3911736.
“The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate”. Scandinavian Journal of Clinical and Laboratory Investigation 45 (2): 97–101. (April 1985). doi:10.3109/00365518509160980. PMID 3923607.
“Cystatin C versus creatinine in determining risk based on kidney function”. The New England Journal of Medicine 369 (10): 932–43. (September 2013). doi:10.1056/NEJMoa1214234. PMC 3993094. PMID 24004120.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000101439 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000027447 - Ensembl, May 2017

handle.net

hdl.handle.net

“Cystatin C, renal function, and cardiovascular risk”. Annals of Internal Medicine 148 (4): 323. (February 2008). doi:10.7326/0003-4819-148-4-200802190-00023. hdl:2268/4787. PMID 18283218. アーカイブ 2023年4月7日 - ウェイバックマシン

harvard.edu

dash.harvard.edu

“Cystatin C deficiency in human atherosclerosis and aortic aneurysms”. The Journal of Clinical Investigation 104 (9): 1191–7. (November 1999). doi:10.1172/JCI7709. PMC 409823. PMID 10545518. アーカイブ 2023年4月7日 - ウェイバックマシン

ui.adsabs.harvard.edu

“Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis”. Proceedings of the National Academy of Sciences of the United States of America 79 (9): 3024–7. (May 1982). Bibcode: 1982PNAS...79.3024G. doi:10.1073/pnas.79.9.3024. PMC 346341. PMID 6283552.

karger.com

“Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review”. American Journal of Nephrology 27 (2): 197–205. (2007). doi:10.1159/000100907. PMID 17361076. アーカイブ 2023年5月21日 - ウェイバックマシン
“Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease”. Dementia and Geriatric Cognitive Disorders 23 (4): 251–7. (2007). doi:10.1159/000100021. PMID 17310123. アーカイブ 2023年4月7日 - ウェイバックマシン

kurtis.it

“Thyroid function differently affects serum cystatin C and creatinine concentrations”. Journal of Endocrinological Investigation 28 (4): 346–9. (April 2005). doi:10.1007/bf03347201. PMID 15966508. オリジナルの2008-06-08時点におけるアーカイブ。. アーカイブ 2008年6月8日 - ウェイバックマシン

lu.se

lup.lub.lu.se

“Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping”. Nature Structural Biology 8 (4): 316–320. (April 2001). doi:10.1038/86188. PMID 11276250. https://lup.lub.lu.se/record/131360.

portal.research.lu.se

“Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping”. Nature Structural Biology 8 (4): 316–20. (April 2001). doi:10.1038/86188. PMID 11276250. アーカイブ 2021年4月19日 - ウェイバックマシン

nice.org.uk

“Chronic kidney disease in adults: assessment and management”. National Institute for Health and Care Excellence (NICE). 2020年11月18日閲覧。アーカイブ 2023年4月7日 - ウェイバックマシン

nih.gov

pubmed.ncbi.nlm.nih.gov

“Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review”. American Journal of Nephrology 27 (2): 197–205. (2007). doi:10.1159/000100907. PMID 17361076. アーカイブ 2023年5月21日 - ウェイバックマシン
“Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis”. Clinical Biochemistry 40 (5–6): 383–91. (March 2007). doi:10.1016/j.clinbiochem.2006.10.026. PMID 17316593.
“Dietary protein and renal function”. Journal of the American Society of Nephrology 3 (11): 1723–37. (May 1993). doi:10.1681/ASN.V3111723. PMID 8329667. アーカイブ 2023年4月7日 - ウェイバックマシン
“Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis”. American Journal of Kidney Diseases 40 (2): 221–6. (August 2002). doi:10.1053/ajkd.2002.34487. PMID 12148093.
“Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes”. Diabetes Care 31 (5): 971–3. (May 2008). doi:10.2337/dc07-1588. PMID 18319326. Archived 2013年4月14日, at Archive.is
“Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study”. Journal of the American Society of Nephrology 16 (5): 1404–12. (May 2005). doi:10.1681/ASN.2004100854. PMC 2429917. PMID 15788478.
“Serum cystatin C as a reliable marker of changes in glomerular filtration rate in children with urinary tract malformations”. The Journal of Urology 175 (1): 303–9. (January 2006). doi:10.1016/S0022-5347(05)00015-7. PMID 16406933.
“Cystatin C: a kidney function biomarker”. Adv Clin Chem 68: 57–69. (2015). doi:10.1016/bs.acc.2014.11.007. PMID 25858868.
“Cystatin C as a biomarker for estimating glomerular filtration rate”. Curr Opin Nephrol Hypertens 24 (3): 295–300. (May 2015). doi:10.1097/MNH.0000000000000115. PMID 26066476.
“Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease”. Annals of Internal Medicine 145 (4): 237–46. (August 2006). doi:10.7326/0003-4819-145-4-200608150-00003. PMID 16908914. アーカイブ 2012年9月11日 - ウェイバックマシン
“A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup”. Geroscience 40 (5–6): 419–436. (December 2018). doi:10.1007/s11357-018-0042-y. PMC 6294728. PMID 30151729.
“Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin”. Therapeutic Drug Monitoring 28 (3): 326–31. (June 2006). doi:10.1097/01.ftd.0000211805.89440.3d. PMID 16778715.
“Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment”. International Journal of Clinical Pharmacology and Therapeutics 42 (2): 93–7. (February 2004). doi:10.5414/cpp42093. PMID 15180169.
“Cystatin C can be affected by nonrenal factors: a preliminary study on leukemia”. Clinical Biochemistry 39 (2): 115–8. (February 2006). doi:10.1016/j.clinbiochem.2005.10.009. PMID 16337174.
“Serum levels of cystatin C in patients with malignancy”. Clinical and Experimental Nephrology 12 (2): 132–139. (April 2008). doi:10.1007/s10157-008-0043-8. PMID 18317874.
“Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression”. Clinical Chemistry 44 (12): 2556–7. (December 1998). doi:10.1093/clinchem/44.12.2556. PMID 9836733.
“Impact of thyroid dysfunction on serum cystatin C”. Kidney International 63 (5): 1944–7. (May 2003). doi:10.1046/j.1523-1755.2003.00925.x. PMID 12675875.
“Thyroid function differently affects serum cystatin C and creatinine concentrations”. Journal of Endocrinological Investigation 28 (4): 346–9. (April 2005). doi:10.1007/bf03347201. PMID 15966508. オリジナルの2008-06-08時点におけるアーカイブ。. アーカイブ 2008年6月8日 - ウェイバックマシン
“Serum cystatin C is sensitive to small changes in thyroid function”. Clinica Chimica Acta; International Journal of Clinical Chemistry 338 (1–2): 87–90. (December 2003). doi:10.1016/j.cccn.2003.07.022. PMID 14637271.
“Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients”. Clinical Chemistry 47 (11): 2055–9. (November 2001). doi:10.1093/clinchem/47.11.2055. PMID 11673383.
“Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients”. Clinica Chimica Acta; International Journal of Clinical Chemistry 300 (1–2): 83–95. (October 2000). doi:10.1016/S0009-8981(00)00298-9. PMID 10958865.
“Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations”. Clinical Chemistry 48 (7): 1123–6. (July 2002). doi:10.1093/clinchem/48.7.1123. PMID 12089191.
“Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement”. Kidney International 65 (4): 1416–21. (April 2004). doi:10.1111/j.1523-1755.2004.00517.x. PMID 15086483.
“Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study”. Archives of Internal Medicine 167 (20): 2213–9. (November 2007). doi:10.1001/archinte.167.20.2213. PMC 3189482. PMID 17998494. オリジナルの2008-06-07時点におけるアーカイブ。. Archived 2008年6月7日, at Archive.is
“Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidin-biotin ELISA assay for its measurement”. Journal of Immunoassay 13 (1): 47–60. (1992). doi:10.1080/15321819208019824. PMID 1569212.
“Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration”. Antiviral Therapy 11 (5): 641–5. (2006). doi:10.1177/135965350601100502. PMID 16964834.
“Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy”. Scandinavian Journal of Clinical and Laboratory Investigation 62 (2): 141–7. (2002). doi:10.1080/003655102753611771. PMID 12004930.
“Cystatin-C and beta trace protein as markers of renal function in pregnancy”. BJOG 112 (5): 575–8. (May 2005). doi:10.1111/j.1471-0528.2004.00492.x. PMID 15842279.
“Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans”. Scandinavian Journal of Clinical and Laboratory Investigation 65 (2): 111–24. (2005). doi:10.1080/00365510510013523. PMID 16025834.
“Chronic kidney disease and mortality risk: a systematic review”. Journal of the American Society of Nephrology 17 (7): 2034–47. (July 2006). doi:10.1681/ASN.2005101085. PMID 16738019.
“Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization”. The New England Journal of Medicine 351 (13): 1296–305. (September 2004). doi:10.1056/NEJMoa041031. PMID 15385656.
“Use of multiple biomarkers to improve the prediction of death from cardiovascular causes”. The New England Journal of Medicine 358 (20): 2107–16. (May 2008). doi:10.1056/NEJMoa0707064. PMID 18480203.
“Cystatin C and the risk of death and cardiovascular events among elderly persons”. The New England Journal of Medicine 352 (20): 2049–60. (May 2005). doi:10.1056/NEJMoa043161. PMID 15901858.
“Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study”. Circulation 115 (2): 173–9. (January 2007). doi:10.1161/CIRCULATIONAHA.106.644286. PMC 2771187. PMID 17190862. Archived 2013年2月23日, at Archive.is
“Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study”. American Heart Journal 155 (1): 62–8. (January 2008). doi:10.1016/j.ahj.2007.08.012. PMID 18082491.
“Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate”. Clinical Chemistry 51 (2): 321–7. (February 2005). doi:10.1373/clinchem.2004.041889. PMID 15563478.
“Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome”. Circulation 110 (16): 2342–8. (October 2004). doi:10.1161/01.CIR.0000145166.44942.E0. PMID 15477399. Archived 2013年2月23日, at Archive.is
“Plasma cystatin-C and development of coronary heart disease: The PRIME Study”. Atherosclerosis 185 (2): 375–80. (April 2006). doi:10.1016/j.atherosclerosis.2005.06.017. PMID 16046222. アーカイブ 2019年4月26日 - ウェイバックマシン
“Is serum cystatin-C a reliable marker for metabolic syndrome?”. The American Journal of Medicine 121 (5): 426–32. (May 2008). doi:10.1016/j.amjmed.2008.01.040. PMID 18456039.
“Cystatin C as a risk factor for outcomes in chronic kidney disease”. Annals of Internal Medicine 147 (1): 19–27. (July 2007). doi:10.7326/0003-4819-147-1-200707030-00004. PMID 17606957. アーカイブ 2012年9月11日 - ウェイバックマシン
“Cystatin C and aging success”. Archives of Internal Medicine 168 (2): 147–53. (January 2008). doi:10.1001/archinternmed.2007.40. PMC 2871318. PMID 18227360. オリジナルの2008-06-07時点におけるアーカイブ。. Archived 2008年6月7日, at Archive.is
“Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)”. American Heart Journal 155 (1): 82–6. (January 2008). doi:10.1016/j.ahj.2007.08.023. PMC 2179893. PMID 18082494.
“Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study”. Archives of Internal Medicine 165 (22): 2666–70. (2005). doi:10.1001/archinte.165.22.2666. PMID 16344426.
“Chronic kidney disease in the elderly--how to assess risk”. The New England Journal of Medicine 352 (20): 2122–4. (May 2005). doi:10.1056/NEJMe058035. PMID 15901867.
“Cystatin C, renal function, and cardiovascular risk”. Annals of Internal Medicine 148 (4): 323. (February 2008). doi:10.7326/0003-4819-148-4-200802190-00023. hdl:2268/4787. PMID 18283218. アーカイブ 2023年4月7日 - ウェイバックマシン
“Glomerular protein sieving and implications for renal failure in Fanconi syndrome”. Kidney International 60 (5): 1885–92. (November 2001). doi:10.1046/j.1523-1755.2001.00016.x. PMID 11703607.
“Renal handling of radiolabelled human cystatin C in the rat”. Scandinavian Journal of Clinical and Laboratory Investigation 56 (5): 409–14. (August 1996). doi:10.3109/00365519609088795. PMID 8869663.
“Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'”. Scandinavian Journal of Clinical and Laboratory Investigation 75 (4): 333–40. (July 2015). doi:10.3109/00365513.2015.1025427. PMC 4487590. PMID 25919022.
“Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options”. Clinical Biochemistry Online ahead of print: 12–20. (June 2020). doi:10.1016/j.clinbiochem.2020.06.002. PMID 32544475.
“Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases”. The Journal of Experimental Medicine 169 (5): 1771–8. (May 1989). doi:10.1084/jem.169.5.1771. PMC 2189307. PMID 2541223.
“The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models”. Brain Pathology 16 (1): 60–70. (January 2006). doi:10.1111/j.1750-3639.2006.tb00562.x. PMC 8095742. PMID 16612983.
“Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping”. Nature Structural Biology 8 (4): 316–320. (April 2001). doi:10.1038/86188. PMID 11276250. https://lup.lub.lu.se/record/131360.
“Glomerular protein sieving and implications for renal failure in Fanconi syndrome”. Proteins 61 (3): 570–578–92. (Nov 2005). doi:10.1002/prot.20633. PMID 16170782.
“Structural characterization of covalently stabilized human cystatin C oligomers”. International Journal of Molecular Sciences 21 (5860): 5860. (Aug 2020). doi:10.3390/ijms21165860. PMC 7461555. PMID 32824145.
“Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models”. Nature Genetics 39 (12): 1440–2. (December 2007). doi:10.1038/ng.2007.29. PMID 18026100.
“Cystatin C modulates cerebral beta-amyloidosis”. Nature Genetics 39 (12): 1437–9. (December 2007). doi:10.1038/ng.2007.23. PMID 18026102.
“Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database”. Nature Genetics 39 (1): 17–23. (January 2007). doi:10.1038/ng1934. PMID 17192785.
“Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease”. Dementia and Geriatric Cognitive Disorders 23 (4): 251–7. (2007). doi:10.1159/000100021. PMID 17310123. アーカイブ 2023年4月7日 - ウェイバックマシン
“Cleavage of cystatin C is not associated with multiple sclerosis”. Annals of Neurology 62 (2): 201–4; discussion 205. (August 2007). doi:10.1002/ana.20968. PMID 17006926.
“Cystatin C deficiency in human atherosclerosis and aortic aneurysms”. The Journal of Clinical Investigation 104 (9): 1191–7. (November 1999). doi:10.1172/JCI7709. PMC 409823. PMID 10545518. アーカイブ 2023年4月7日 - ウェイバックマシン
“Cysteine protease activity in the wall of abdominal aortic aneurysms”. Journal of Vascular Surgery 46 (6): 1260–6. (December 2007). doi:10.1016/j.jvs.2007.08.015. PMID 18155003.
“Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases”. The American Journal of Pathology 170 (3): 809–17. (March 2007). doi:10.2353/ajpath.2007.060522. PMC 1864891. PMID 17322367. ^{[リンク切れ]}
“Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm”. Polish Journal of Pathology 50 (2): 83–6. (1999). PMID 10481531.
“Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms”. The British Journal of Surgery 91 (1): 86–9. (January 2004). doi:10.1002/bjs.4364. PMID 14716800.
“Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms”. The British Journal of Surgery 88 (11): 1472–5. (November 2001). doi:10.1046/j.0007-1323.2001.01911.x. PMID 11683743.
“CST3 genotype associated with exudative age related macular degeneration”. The British Journal of Ophthalmology 86 (2): 214–9. (February 2002). doi:10.1136/bjo.86.2.214. PMC 1771004. PMID 11815350.
“The role of cathepsins in ocular physiology and pathology”. Experimental Eye Research 84 (3): 383–8. (March 2007). doi:10.1016/j.exer.2006.05.017. PMID 16893541.
“Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis”. British Journal of Cancer 90 (10): 1961–8. (May 2004). doi:10.1038/sj.bjc.6601830. PMC 2409457. PMID 15138478.
“Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis”. Clinical Cancer Research 6 (2): 505–11. (February 2000). PMID 10690531. Archived 2013年2月23日, at Archive.is
“Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies”. BJOG 110 (9): 825–30. (September 2003). doi:10.1111/j.1471-0528.2003.02051.x. PMID 14511964.
“Cystatin C and preeclampsia: a case control study”. Renal Failure 30 (1): 89–95. (2008). doi:10.1080/08860220701742229. PMID 18197549.
“Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia”. Acta Obstetricia et Gynecologica Scandinavica 86 (8): 921–6. (2007). doi:10.1080/00016340701318133. PMID 17653875.
“Increased cystatin C expression in the pre-eclamptic placenta”. Molecular Human Reproduction 13 (3): 189–95. (March 2007). doi:10.1093/molehr/gal111. PMID 17227816.
“Adult cystatin C reference intervals determined by nephelometric immunoassay”. Clinical Biochemistry 40 (13–14): 1084–7. (September 2007). doi:10.1016/j.clinbiochem.2007.05.011. PMID 17624320.
“Serum cystatin C may be a better marker of renal impairment than creatinine”. Journal of the American Geriatrics Society 51 (11): 1674; author reply 1674-5. (November 2003). doi:10.1046/j.1532-5415.2003.515244.x. PMID 14687406.
“Measurement of serum creatinine--current status and future goals”. The Clinical Biochemist. Reviews 27 (4): 173–84. (November 2006). PMC 1784008. PMID 17581641.
“Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program”. Clinical Chemistry 52 (1): 5–18. (January 2006). doi:10.1373/clinchem.2005.0525144. PMID 16332993.
“Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III)”. American Journal of Kidney Diseases 51 (3): 385–94. (March 2008). doi:10.1053/j.ajkd.2007.11.019. PMID 18295054.
“Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children”. Archives of Disease in Childhood 82 (1): 71–5. (January 2000). doi:10.1136/adc.82.1.71. PMC 1718178. PMID 10630919.
“Cystatin C reference values and aging”. Clinical Biochemistry 39 (6): 658–61. (June 2006). doi:10.1016/j.clinbiochem.2006.03.017. PMID 16730690.
“Cystatin C as a marker of GFR--history, indications, and future research”. Clinical Biochemistry 38 (1): 1–8. (January 2005). doi:10.1016/j.clinbiochem.2004.09.025. PMID 15607309.
“Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD”. American Journal of Kidney Diseases 51 (3): 395–406. (March 2008). doi:10.1053/j.ajkd.2007.11.018. PMC 2390827. PMID 18295055.
“Cystatin C: research priorities targeted to clinical decision making”. American Journal of Kidney Diseases 51 (3): 358–61. (March 2008). doi:10.1053/j.ajkd.2008.01.002. PMID 18295049.
“Overweight, obesity, and elevated serum cystatin C levels in adults in the United States”. The American Journal of Medicine 121 (4): 341–8. (April 2008). doi:10.1016/j.amjmed.2008.01.003. PMC 3049932. PMID 18374694.
“A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study”. BMC Medical Genetics 8 Suppl 1 (Suppl 1): S10. (September 2007). doi:10.1186/1471-2350-8-S1-S10. PMC 1995611. PMID 17903292.
“Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping”. Nature Structural Biology 8 (4): 316–20. (April 2001). doi:10.1038/86188. PMID 11276250. アーカイブ 2021年4月19日 - ウェイバックマシン
“Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis”. Proceedings of the National Academy of Sciences of the United States of America 79 (9): 3024–7. (May 1982). Bibcode: 1982PNAS...79.3024G. doi:10.1073/pnas.79.9.3024. PMC 346341. PMID 6283552.
“Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system”. Scandinavian Journal of Clinical and Laboratory Investigation 39 (7): 619–26. (November 1979). doi:10.3109/00365517909108866. PMID 119302.
“Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate”. Acta Medica Scandinavica 218 (5): 499–503. (1985). doi:10.1111/j.0954-6820.1985.tb08880.x. PMID 3911736.
“The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate”. Scandinavian Journal of Clinical and Laboratory Investigation 45 (2): 97–101. (April 1985). doi:10.3109/00365518509160980. PMID 3923607.
“Cystatin C versus creatinine in determining risk based on kidney function”. The New England Journal of Medicine 369 (10): 932–43. (September 2013). doi:10.1056/NEJMoa1214234. PMC 3993094. PMID 24004120.

ncbi.nlm.nih.gov

qub.ac.uk

pure.qub.ac.uk

“Plasma cystatin-C and development of coronary heart disease: The PRIME Study”. Atherosclerosis 185 (2): 375–80. (April 2006). doi:10.1016/j.atherosclerosis.2005.06.017. PMID 16046222. アーカイブ 2019年4月26日 - ウェイバックマシン

rbac.org.br

“Cystatin C: a promising biomarker to evaluate renal function”. Revista Brasileira de Analises Clinicas 49 (3). (January 1, 2017). doi:10.21877/2448-3877.201600446 2020年11月18日閲覧。. アーカイブ 2023年4月10日 - ウェイバックマシン

ulg.ac.be

orbi.ulg.ac.be

“Cystatin C, renal function, and cardiovascular risk”. Annals of Internal Medicine 148 (4): 323. (February 2008). doi:10.7326/0003-4819-148-4-200802190-00023. hdl:2268/4787. PMID 18283218. アーカイブ 2023年4月7日 - ウェイバックマシン

web.archive.org

wikipedia.org

en.wikipedia.org

GRCh38: Ensembl release 89: ENSG00000101439 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000027447 - Ensembl, May 2017